Biofrontera
Manufacturing · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Hemmelrather Weg 201, Leverkusen, Nordrh...Phone Number
+49 21487632Website
www.biofrontera.comRevenue
$27.9 MillionStock Symbol
B8FK.DEIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Biofrontera
Biofrontera is headquartered in Leverkusen, Germany and specializes in the development and sale of dermatological drugs and medical cosmetics. Biofrontera was founded in 1997 and develops and markets innovative products for the care, protection and treatment of the skin.Explore more
Biofrontera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biofrontera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Biofrontera
Website visits: Recent activity has been detected on your website
Check if Biofrontera has recently received funding, and reach out quickly before it becomes old news!
Check out if Biofrontera is spiking on competitors!
Funding: Get notified immidiatlly once Biofrontera has new funding data
Earning: See what the market has to say on Biofrontera recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Biofrontera launches new products
Biofrontera, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Biofrontera had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Biofrontera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biofrontera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biofrontera.
Biofrontera financials insights
Gather financial insights about Biofrontera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$29.9M
Stock Offering
$18M
Biofrontera Tech Stack
A closer look at the technologies used by Biofrontera
Most Recent Scoops
Project
Biofrontera announced that as of July 1, 2025, CMS has officially listed Ameluz in its MUE files for the use of up to three tubes per treatment, following FDA approval of a change in patient information in fall 2024.
Healthcare Technology, Regulations
Project
Biofrontera has completed its phase three trial for superficial basal cell carcinoma indication, including one-year follow-up data, aiming to offer a non-invasive treatment option with high efficacy and positive cosmetic outcomes.
Medical Research, Pharmaceuticals, Clinical Operations
Earnings
reported total operating expenses of $14.1 million for Q2 2025, compared to $12.9 million in Q2 2024, with a $1.7 million decrease in cost of revenue.
Earnings, Accounting, Legal Affairs, Financial Reporting, Finance
Project
Biofrontera announced plans to take over manufacturing of Ameluz, which is expected to provide better control of the entire process, shorter lead times, and improved operational and financial positioning, particularly regarding inventory levels and working capital.
Logistics / Supply Chain, Inventory Management, Manufacturing Operations
Project
Medical Research, Pharmaceuticals, Clinical Operations
Biofrontera News & Media
Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript
Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q3 2023 Earnings Conference Call November 10, 2023 10:00 AM ETCompany ParticipantsTirth Patel - IRHermann Luebbert -...Biofrontera Inc. (BFRI) Q2 2023 Earnings Call Transcript
Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ETCompany ParticipantsTirth Patel - Investor RelationsHermann Luebbert - Executive Chairman...Biofrontera Inc. (BFRI) Q1 2023 Earnings Call Transcript
Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ETCompany ParticipantsTirth Patel - Investor RelationsHermann Luebbert - Executive Chairman and...Biofrontera, Inc. (BFRI) Q4 2022 Earnings Call Transcript
Biofrontera, Inc. (NASDAQ:NASDAQ:BFRI) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ETCompany ParticipantsErica Monaco - CEO, COO, Treasurer & SecretaryFred Leffler -...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biofrontera
Sign Up For FreeTo access detailed company insights
Biofrontera is headquartered in Leverkusen, Germany and specializes in the development and sale of dermatological drugs and medical cosmetics. Biofrontera was founded in 1997 and develops and markets innovative products for the care, protection and treatment of the skin.... Read More
